Literature DB >> 7827394

Psychotropic drugs, aging and community care.

M Philpot1, A Puranik.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7827394     DOI： 10.2165/00002512-199405040-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  32 in total

Review 1.  Recognition and management of depression in general practice: consensus statement.

Authors:  E S Paykel; R G Priest
Journal:  BMJ       Date:  1992-11-14

2.  Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study.

Authors:  A F Oberholzer; C Hendriksen; A U Monsch; B Heierli; H B Stähelin
Journal:  Int Psychogeriatr       Date:  1992       Impact factor: 3.878

3.  Psychotropic drugs in Australia: consumption patterns.

Authors:  A Lockwood; C G Berbatis
Journal:  Med J Aust       Date:  1990-11-19       Impact factor: 7.738

4.  Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.

Authors:  G Chatellier; L Lacomblez
Journal:  BMJ       Date:  1990-02-24

5.  Selective serotonin reuptake inhibitors.

Authors:  J G Edwards
Journal:  BMJ       Date:  1992-06-27

6.  A chart review study of late-onset and early-onset schizophrenia.

Authors:  G D Pearlson; L Kreger; P V Rabins; G A Chase; B Cohen; J B Wirth; T B Schlaepfer; L E Tune
Journal:  Am J Psychiatry       Date:  1989-12       Impact factor: 18.112

7.  Tetrahydroaminoacridine and Alzheimer's disease.

Authors:  E J Byrne; T Arie
Journal:  BMJ       Date:  1994-04-02

Review 8.  Prescribing CNS drugs for elderly patients.

Authors:  K Ghose
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

Review 9.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

10.  Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics.

Authors:  R P Gleason; L S Schneider
Journal:  J Clin Psychiatry       Date:  1990-03       Impact factor: 4.384
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.